Mental health clinical trials span depression, anxiety, bipolar disorder, schizophrenia, eating disorders, ADHD, sleep disorders, and substance use disorders — representing the most prevalent category of disability-causing conditions globally. Mental health research is undergoing a paradigm shift as biological understanding deepens: from purely symptom-based diagnosis to biomarker-informed phenotyping, and from first-generation neurotransmitter-targeting drugs to precision approaches based on neurocircuit function, genetics, and inflammatory markers.
Active trial areas include psychedelic-assisted psychotherapy (psilocybin, MDMA, ketamine), digital therapeutics validated as prescription medical devices, transcranial magnetic stimulation with personalized targeting using fMRI biomarkers, inflammatory markers (CRP, IL-6) as predictors of antidepressant response, and integrated care models combining pharmacotherapy with technology-delivered psychosocial support. ADHD trials increasingly focus on non-stimulant agents to address cardiovascular safety concerns in adults.
Most mental health trials require a structured diagnostic interview (SCID or MINI) to confirm diagnosis; severity scales (PHQ-9, GAD-7, PANSS) determine eligibility and serve as primary endpoints.
Frequently Asked Questions — mental health impairment Clinical Trials
How many clinical trials are currently recruiting for mental health impairment?
ClinicalMetric currently tracks 1 actively recruiting clinical trials for mental health impairment, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 1. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for mental health impairment?
mental health impairment research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a mental health impairment clinical trial?
Eligibility criteria for mental health impairment trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Bespoke Clinical Research 1 trial
Recruiting Clinical Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional.
Full Disclaimer ·
Last Reviewed: April 2026 ·
Data Methodology